ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Nexus AG's annualized net income for the quarter that ended in Sep. 2025 was €30.6 Mil. Nexus AG's average Total Stockholders Equity over the quarter that ended in Sep. 2025 was €297.7 Mil. Therefore, Nexus AG's annualized ROE % for the quarter that ended in Sep. 2025 was 10.27%.
The historical rank and industry rank for Nexus AG's ROE % or its related term are showing as below:
CHIX:NXUd'
s ROE % Range Over the Past 10 Years
Min: 8.81 Med: 10.15 Max: 13.25
Current: 11.89
During the past 13 years, Nexus AG's highest ROE % was 13.25%. The lowest was 8.81%. And the median was 10.15%.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Sep. 2025) net income data. The Revenue data used here is four times the quarterly (Sep. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Nexus AG ROE % Related Terms
Nexus AG ROE % Historical Data
* Premium members only.
The historical data trend for Nexus AG's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Nexus AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexus AG ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nexus AG's ROE % distribution charts can be found below:
* The bar in red indicates where Nexus AG's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Sep. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Nexus AG (CHIX:NXUD) has a ROE % of 10.27% as of Sep. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Nexus AG and its competitors. This is near median its historical median of 10.15. Over the past decade, Nexus AG's ROE % has ranged from 8.81 to 13.25.
Is Nexus AG's ROE % too high?
Nexus AG's current ROE % of 10.27% is near median its 10-year median of 10.15. Over the past 10 years, this metric has ranged from a low of 8.81 to a high of 13.25. The Healthcare Providers & Services industry median ROE % is 5.72. Nexus AG's value of 10.27% is 79.5% above this industry median. Overall, Nexus AG has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Nexus AG's ROE % compare to VEEV and GEHC?
Nexus AG's ROE % of 10.27% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROE % is 5.72. Nexus AG's value of 10.27% is 79.5% above this benchmark. Historically, Nexus AG's own ROE % has ranged from 8.81 to 13.25 over the past decade. While the company's 10-year median is 10.15 vs. the industry median of 5.72, Nexus AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexus AG's current ROE % of 10.27% is 79.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Nexus AG and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexus AG's current ROE % is 10.27%, which is near median its own 10-year median of 10.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus AG stock overvalued right now?
Nexus AG (CHIX:NXUD) has a current ROE % of 10.27%. The stock's GF Value™ is €71.37, compared to a current price of €68.60 — trading 3.9% below its estimated fair value. The current ROE % is 10.27%, which is near median its 10-year median of 10.15 and 79.5% above the Healthcare Providers & Services industry median of 5.72. Nexus AG's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Nexus AG (CHIX:NXUD), the current ROE % is 10.27% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexus AG (CHIX:NXUD) Overvalued in 2026?
Based on GuruFocus' analysis, Nexus AG stock appears to be undervalued.
The current stock price of €68.60 is trading 3.9% below its estimated GF Value™ of €71.37.
Key valuation signals for CHIX:NXUD:
ROE %: 10.27% (near median its 10-year median of 10.15)
GF Value™: €71.37 vs. price of €68.60 (3.9% below fair value)
Industry Position: 79.5% above the Healthcare Providers & Services median
No single metric tells the full story. See the CHIX:NXUD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, and IT services for IT operations especially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.
78GF Score
Get the complete analysis for CHIX:NXUD
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:NXUD has been successfully added to your 
